Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,241 total articles
MPLX reported a quarter that felt soft at face value, but underlying cash generation, an intact distribution and modest deleveraging mean the business risk just dropped. The stock trades at roughly $60, yields ~7.1%, and carries tangible upside if volumes and project execution remain steady. This trade idea lays out an entry at $59.50, a stop at $5…
Innoviva is facing genuine royalty roll-off concerns, but the stock's current valuation - roughly $1.52B market cap, P/E ~3, EV/EBITDA ~5.8 and an implied FCF yield near 12% - already factors in a dramatic earnings collapse. That makes a tactical long with defined risk-management attractive. This trade plan lays out entry, stop and layered targets …
NRG's recent LS Power acquisition (13 GW added) and raised FY26 guidance materially enlarge its generation footprint and optionality into data-center power. The numbers show upgraded EBITDA and FCF guidance, but the balance sheet and prior quarterly noise argue for an active, risk-managed long. This trade idea targets $150 with a $110 stop over a 1…
Radian's recent quarter disappointed as newly acquired P&C and specialty lines pressured results, but the balance sheet remains healthy, the stock trades below 10x earnings, and the company's strategic pivot (including the $1.7B Inigo deal) points to upside. This is a tactical long for the mid term (45 trading days) with defined entry, stop and tar…
Consolidated Edison (ED) is a classic regulated-utility buy: predictable cash flow, a rising dividend (52 consecutive years), and a reasonable valuation (P/E ~18, P/B ~1.4). I expect low-single-digit EPS growth, a 3%+ starting yield, and the potential for multiple expansion and capital appreciation that combine to deliver double-digit annualized to…
Meta's multi-year AI investment is expensive, but the company now has a credible pathway to monetize a ~3.6 billion user base with AI-driven ads and experiences. Recent weakness has left the stock attractively priced relative to the upside from AI-enabled product improvements. This trade idea lays out an actionable long with entry, stop, and target…
Sanofi is trading at $43.26 with a $103.1B market capitalization, a 4.11% yield, and recent top-line momentum led by Dupixent. Q2 showed 17.8% constant-currency sales growth and management upgraded 2026 guidance. The stock’s valuation, current technicals and modest short interest create an asymmetric long opportunity for investors willing to hold t…
Alphabet combines a dominant ad/search franchise with fast-growing cloud AI demand and a pristine balance sheet. At ~$364.59 the stock trades at a mid-teens P/E with meaningful free cash flow and margin optionality. This trade idea lays out a concrete entry, stop and target for a long-term (180 trading days) position and the catalysts and risks to …
First Solar (FSLR) combines industry-leading module technology with strong free cash flow, no meaningful debt, and a mid-teens P/E. The stock pulled back into the $225-$240 area after recent volatility. For investors willing to own a high-conviction solar name through policy and project execution noise, this offers an attractive risk-reward: enter …
Rocket Lab has shifted decisively from a pure-play commercial launcher to a vertically integrated space and defense company. Recent contract wins totaling hundreds of millions, a growing backlog and a strategic Iridium acquisition create a path to 2027 profitability. The valuation is rich, but the balance sheet, contract cadence and a clear go-to-m…
Palantir’s Q2 blowout and follow-through rally have combined fundamental acceleration and technical confirmation. Despite steep multiples, revenue growth, FCF generation and improving breadth make a mid-term long trade attractive. Entry at $160, stop at $140, target $200 with a 45 trading-day horizon.
Amkor (AMKR) has been a direct beneficiary of the AI-driven bump in packaging and test demand but still trades at reasonable multiples. The company's $1.69B Q1 revenue beat, optimistic Q2 guidance, and a 10-year capacity partnership with TSMC argue for upside. I present a swing trade plan to capture re-rating into $75 while keeping a disciplined st…
Zeta Global's revenue acceleration and sizable free cash flow have finally begun to show up at the bottom line. With a visible partnership pipeline and recurring revenue tailwinds, the stock looks tradeable on a mid-term horizon. This plan defines an entry, stop and target while laying out catalysts and the key risks that would invalidate the setup…
The market appears fixated on short-term launch and regulatory headlines while underweighting recurring revenue potential and margin leverage in Starlink plus strategic optionality from Starship commercialization. This trade idea buys that disconnect: enter at $250.00, target $350.00, stop $200.00 over a 180-trading-day horizon.
Palantir's accelerating AIP adoption and clearer path to higher-margin revenue have convinced me to raise my target to $38. This is a tactical long for patient, risk-aware traders: entry at $25.00, stop at $21.00, target at $38.00 over a long-term (180 trading days) horizon.
ASML has been punished recently on headlines about a Chinese DUV vendor and an AI sector pullback. Fundamentals and capacity math still favor ASML's EUV franchise. This is a tactical long: enter on the dip, size for a mid-term (45 trading days) swing, protect with a tight stop and take profits into a known resistance band near $1,900.
ON Semiconductor's $7 billion Synaptics acquisition and management's synergy roadmap materially change the company's growth profile. With free cash flow of $1.5B, an EPS of $2.65 and a reasonable balance sheet, I am raising my price target to reflect a re-rated multiple for physical-AI exposure. This is an actionable idea: buy near $76.50, target $…
BrainsWay (BWAY) is a niche leader in Deep Transcranial Magnetic Stimulation (Deep TMS) with recent regulatory wins and research grants that support adoption. With a ~$608M market cap and a compact workforce, the company can grow clinic penetration without heavy capex. This trade idea takes a mid-term bullish stance into Q2 results and potential co…
Palantir crushed Q2, sent the stock up 27% and left momentum high but valuation very rich. This trade idea lays out a disciplined long entry after the post-earnings rally, with exact entry, stop and target, plus the fundamental and technical reasoning that justifies a mid-term swing trade.
Rigel is no longer just a clinical-stage story. With an FDA-approved oral PROTAC (VEPPANU) and an established hematology product (Tavalisse), the company sits at an attractive valuation (market cap ~$775M) with near-term commercial catalysts and demonstrated free cash flow. This trade buys a pullback into technical support and positions for revenue…
SCHD (Schwab US Dividend Equity ETF) offers 3%+ yield, a low cost structure and exposure to 100 high-quality dividend payers. With bullish technicals and a recent stretch of outperformance, a mid-term long trade sized to limit downside and capture income plus rally upside is an actionable way to reduce portfolio volatility in a risky market environ…
Miami International (MIAX) looks like a growth exchange still in the early innings of network effects. Rising liquidity, a debt-free balance sheet and expanding product mix support continued upside. I upgrade MIAX to a mid-term long trade with clear entry, stop and target levels.
GEMI's collapse from its IPO highs priced in a lot of bad news. With market cap near $0.5B, an enterprise value under $400M and heavy short interest, the stock is priced for failure. A disciplined long entry at $4.05 with a $3.70 stop and a $6.50 target offers asymmetric upside if the company can stabilize operations, provide clearer guidance on it…
Pinterest is trading well below its 52-week high after a year of advertising bounces and founder liquidity events. The stock offers $1.2B in free cash flow, an enterprise value near $14.9B and a valuation that looks reasonable versus its cash-generation profile. This trade targets a rebound to $30 over a multi-month position while protecting downsi…
Broadcom has faced near-term noise from compute-cycle weakness, but a structural shift toward optical interconnects across cloud, AI, and networking should drive durable revenue leverage. This trade idea upgrades Broadcom to a long stance. Entry $1000.00, target $1300.00, stop $850.00. Time horizon: long term (180 trading days).
